Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» abicipar
abicipar
FDA rejects AbbVie's eye drug, citing safety concerns
BioPharma Dive
Fri, 06/26/20 - 01:00 pm
Allergan
AbbVie
FDA
abicipar
Molecular Partners
wet age-related macular degeneration
Allergan eye drug fails to impress on safety, upping pressure ahead of key meeting
Biopharma Dive
Wed, 04/3/19 - 12:22 pm
Allergan
abicipar
wet age-related macular degeneration
Does an improved safety profile strengthen Allergan's case for a wet AMD challenge to Lucentis?
Endpoints
Tue, 04/2/19 - 12:04 pm
Allergan
abicipar
wet age-related macular degeneration
Lucentis
Molecular Partners
Allergan’s eye contender cannot knock Eylea off its perch
EP Vantage
Sun, 07/22/18 - 12:24 pm
Regeneron
Eylea
wet age-related macular degeneration
Allergan
molecular
abicipar
Actavis keeps its Phase III promise with Molecular Partners' eye drug
Fierce Biotech
Mon, 05/11/15 - 09:21 am
Actavis
Molecular Partners
abicipar
wet age-related macular degeneration
